Home > Research Areas > Cardiovascular Disease
Cat. No. Product name CAS No.
DC11923 BMS-986120 Featured

BMS-986120 (BMS986120) is a potent, selective, orally bioavailable, and reversible PAR4 antagonist with Kd of 0.098 nM for human PAR4.

1478712-37-6
DCAPI1140 Bumetanide Featured

Bumetanide

28395-03-1
DC9185 Candesartan cilexetil Featured

Candesartan Cilexetil (TCV-116) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

145040-37-5
DC9142 Candesartan

Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM.

139481-59-7
DC7005 Cangrelor free acid Featured

Cangrelor is a P2Y12 inhibitor, and was approved in June 2015 as an antiplatelet drug for intravenous application. Cangrelor is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggrega

163706-06-7
DC7990 Cariporide

Cariporide is a selective Na+/H+ exchanger isoform 1 (NHE1) inhibitor (IC50 values are 0.05, 3 and 1000 μM for NHE1, NHE3 and NHE2 respectively).

159138-80-4
DC8471 CGS 21680 hydrochloride Featured

CGS 21680 hydrochloride is an A2A adenosine receptor agonist (Ki = 27 nM).

124431-80-7
DC9160 Cilnidipine Featured

Cilnidipine(FRC8653) is a dual L- and N-type calcium channel blocker and displays antihypertensive, sympatholytic and neuroprotective activity.

132203-70-4
DC9174 Cinepazide maleate

Cinepazide Maleate is a vasodilator.

26328-04-1
DC11098 CKD-519

CKD-519 (Rocacetrapib, CKD519) is a potent, selective cholesteryl ester transfer protein (CETP) inhibitor, inhibits the CETP-mediated transfer of cholesteryl ester in human serum with IC50 of 2.3 nM.

1402796-27-3
DC9380 Cleviprex Featured

Clevidipine(Clevidipine) is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension.

167221-71-8
DC3147 Clopidogrel hydrogensulfate

Clopidogrel (Plavix) is an oral, thienopyridine class antiplatelet agent.

120202-66-6
DCAPI1417 Clopidogrel

Clopidogrel is an irreversible inhibitor of the P2Y12 receptor, which is responsible for initiating signal transduction via a GPCR. The signal cascade initiates platelet aggregation and thus clopidogrel has the effect of “thinning” the blood.

113665-84-2
DC8913 Dabigatran etexilate mesylate Featured

Dabigatran etexilate mesylate (BIBR 1048MS) is the orally active prodrug of dabigatran. Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.

872728-81-9
DC7397 Darapladib Featured

Darapladib is a selective and orally active inhibitor of Lp-PLA2 (IC50= 270 pM)

356057-34-6
DCAPI1152 Diltiazem HCl (Tiazac)

Diltiazem HCl (Tiazac)

33286-22-5
DC10446 (3R,4S,5S)-tert-butyl 3-Methoxy-5-Methyl-4-(MethylaMino)heptanoate hydroc hloride Featured

Diltiazem hydrochloride is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist).

120205-48-3
DCAPI1457 Dronedarone Hydrochloride

Dronedarone is a Class III antiarrhythmic and a multi-channel blocker for atrial fibrillation. It blocks potassium and sodium and is a calcium channel protein inhibitor.

141625-93-6
DC9595 E-4031

E-4031 is a benzenesulfonamide antiarrhythmic agent; blocks the ATP-sensitive potassium channel.

113559-13-0
DC8533 E5555 hydrobromide

E5555 shows potent inhibitory effects on human platelet aggregation induced by thrombin and TRAP with IC values of 0.064 and 0.031 μM respectively.

474550-69-1
DC8305 Edoxaban Featured

Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention

480449-71-6
DC8793 Edoxaban tosylate monohydrate Featured

Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention

1229194-11-9
Page 2 / Total 5 FirstPrevNextLastGoto